Drugs / Plague vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02596308 | Oct → Dec 2014 | plague | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Plague vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02596308 ↗ |
| Known as | F1+rV | “The new plague vaccine (F1+rV) induced a robust immune response up to 12 months and showed a good safety profile in adults aged 18-55 years.” PMID 29927704 ↗ Jul 2018 |
| Modality | Vaccine | “To evaluate the one-year immunogenicity and safety of a subunit plague vaccine.” PMID 29927704 ↗ Jul 2018 |